January 31st, 2014
A (Not So) New Drug Landscape for Pulmonary Arterial Hypertension
John Ryan, MD
John Ryan offers a primer on three newly approved drugs for pulmonary arterial hypertension.
NEJM Journal Watch — Recent Cardiology Articles- Is Routine Defibrillation Testing Necessary for Patients Undergoing Subcutaneous ICD Implantation?
- RSV Infection Substantially Raises Risk for Cardiovascular Events
- Is Cardiovascular Risk Sustained After SARS-CoV-2 Infection?
- Can AI Interpret Clinical Echocardiograms?
- Managing Obesity in Heart Failure: New Guidance from ACC